Asn Neuro: Impact Factor, Indexing, Publication Time & Fees


The Asn Neuro is reputed journal publishes research related to Neurology (clinical) (Q1); Neuroscience (miscellaneous) (Q1). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Asn Neuro: Details

Journal TitleASN Neuro
PublisherSAGE Publications Inc.
Publication CountryUnited Kingdom
ISSN17590914
Publication AreaMedicine; Neuroscience
Publication LanguageENG
Review ProcessDouble anonymous peer review
Scopus IndexedYes

Asn Neuro Impact Factor

The Impact Factor of Asn Neuro in 2026 is 4.4.

Journal Quartile

The Asn Neuro is ranked in Q2.

Indexing

The Asn Neuro is indexed in: DOAJ, Web of Science.

Publication Fee

There is a fee to publish in the Asn Neuro. The publication fee is 2630 USD.

The journal also offers a fee waiver policy.

Publication Time

The Asn Neuro takes an average of 10 weeks to publish research papers.

Journal Official Website

The official website of the journal is https://www.tandfonline.com/journals/tasn20.

Please visit only official website of the journal to submit research papers.



Similiar journals to publish


ASN Neuro
ISSN:
Publisher: SAGE Publications Inc.
Journal Scope: Neurology (clinical) (Q1); Neuroscience (miscellaneous) (Q1)

Neuro-Oncology
ISSN:
Publisher: Oxford University Press
Journal Scope: Cancer Research (Q1); Neurology (clinical) (Q1); Oncology (Q1)

Progress in Neuro-Psychopharmacology and Biological Psychiatry
ISSN:
Publisher: Elsevier Inc.
Journal Scope: Biological Psychiatry (Q1); Pharmacology (Q1)

Neuro-Oncology Advances
ISSN:
Publisher: Oxford University Press
Journal Scope: Neurology (clinical) (Q1); Oncology (Q1); Surgery (Q1)

Journal of Neuro-Oncology
ISSN:
Publisher: Springer
Journal Scope: Cancer Research (Q2); Neurology (Q2); Neurology (clinical) (Q2); Oncology (Q2)

Neuro-Oncology Practice
ISSN:
Publisher: Oxford University Press
Journal Scope: Medicine (miscellaneous) (Q1); Neurology (Q2); Oncology (Q2)